In a regulatory filing, Dice Therapeutics disclosed that Ra Capital bought 509K shares of common stock on March 28th in a total transaction size of $14.8M. Shares of Dice Therapeutics are up 2% afterhours at $29.24.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on DICE:
- This Major Insider is Loading Up on Dice (NASDAQ:DICE) Stock
- DICE Therapeutics to Participate in the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference
- Cantor biopharma/biotech analysts hold analyst/industry conference call
- Dice Therapeutics reports Q4 EPS (51c), consensus (49c)
- DICE Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights
